XML 70 R60.htm IDEA: XBRL DOCUMENT v3.23.2
INTANGIBLE ASSETS AND GOODWILL - Narrative (Details)
2 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2023
USD ($)
Oct. 01, 2022
USD ($)
Sep. 30, 2022
USD ($)
Jun. 30, 2022
USD ($)
reporting_unit
Jun. 30, 2023
USD ($)
Dec. 31, 2022
USD ($)
Sep. 30, 2022
USD ($)
Jun. 30, 2022
USD ($)
Mar. 31, 2022
USD ($)
Jun. 30, 2023
USD ($)
Jun. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Goodwill [Line Items]                          
Asset impairments         $ 37,000,000     $ 6,000,000   $ 50,000,000 $ 14,000,000    
Finite-lived intangible assets $ 3,601,000,000       3,601,000,000 $ 4,102,000,000       3,601,000,000   $ 4,102,000,000  
Goodwill impairment                       824,000,000  
Goodwill 11,628,000,000       11,628,000,000 11,547,000,000       11,628,000,000   11,547,000,000 $ 12,457,000,000
Accumulated goodwill impairment charges 5,004,000,000       5,004,000,000         5,004,000,000      
Bausch + Lomb                          
Goodwill [Line Items]                          
Number of reporting units | reporting_unit       3                  
Salix                          
Goodwill [Line Items]                          
Goodwill impairment                       0  
Goodwill 3,159,000,000       3,159,000,000 $ 3,159,000,000       3,159,000,000   $ 3,159,000,000 $ 3,159,000,000
Dermatology Reporting Unit                          
Goodwill [Line Items]                          
Reporting unit, impairment test, long-term growth rate     1.00% 1.00%     1.00% 1.00% 1.00%   1.00%    
Reporting unit, impairment test, estimated cash flows, discount rate     10.50% 10.00%     10.50% 10.00% 9.00%   10.00%    
Fair value of reporting value, greater than its carrying value                 2.00%        
Goodwill impairment             $ 119,000,000 $ 83,000,000 $ 0        
Reporting unit, impairment test, estimated cash flows, change in discount rate       1.00%       1.00%     1.00%    
Goodwill     $ 480,000,000       $ 480,000,000            
Vision Care, Surgical and Pharmaceuticals Reporting Units | Bausch + Lomb                          
Goodwill [Line Items]                          
Fair value of reporting value, greater than its carrying value       25.00%   25.00%   25.00%     25.00% 25.00%  
Goodwill impairment       $ 0   $ 0              
Salix Reporting Unit                          
Goodwill [Line Items]                          
Reporting unit, impairment test, long-term growth rate     2.50%       2.50%            
Fair value of reporting value, greater than its carrying value     5.00%       5.00%            
Goodwill impairment             $ 0            
Neurology and Other Reporting Unit                          
Goodwill [Line Items]                          
Reporting unit, impairment test, long-term growth rate           (2.50%)           (2.50%)  
Reporting unit, impairment test, estimated cash flows, discount rate           10.25%           10.25%  
Goodwill impairment   $ 622,000,000                      
Goodwill           $ 1,439,000,000           $ 1,439,000,000  
Minimum | Vision Care, Surgical and Pharmaceuticals Reporting Units | Bausch + Lomb                          
Goodwill [Line Items]                          
Reporting unit, impairment test, long-term growth rate       2.00%   2.00%   2.00%     2.00% 2.00%  
Reporting unit, impairment test, estimated cash flows, discount rate       9.00%   9.50%   9.00%     9.00% 9.50%  
Minimum | Salix Reporting Unit                          
Goodwill [Line Items]                          
Reporting unit, impairment test, estimated cash flows, discount rate     9.75%       9.75%            
Maximum | Vision Care, Surgical and Pharmaceuticals Reporting Units | Bausch + Lomb                          
Goodwill [Line Items]                          
Reporting unit, impairment test, long-term growth rate       3.00%   3.00%   3.00%     3.00% 3.00%  
Reporting unit, impairment test, estimated cash flows, discount rate       11.50%   12.25%   11.50%     11.50% 12.25%  
Maximum | Salix Reporting Unit                          
Goodwill [Line Items]                          
Reporting unit, impairment test, estimated cash flows, discount rate     10.00%       10.00%            
Uceris Foam                          
Goodwill [Line Items]                          
Asset impairments         37,000,000                
Impairment of intangible assets         37,000,000                
Xifaxan Branded Products                          
Goodwill [Line Items]                          
Impairment of intangible assets 0   $ 0                    
Finite-lived intangible assets $ 2,424,000,000       $ 2,424,000,000         $ 2,424,000,000      
Finite lived intangible assets, useful life 54 months       54 months         54 months      
Xifaxan Branded Products | Salix | Revenue from Contract with Customer, Segment Benchmark | Product Concentration Risk                          
Goodwill [Line Items]                          
Concentration risk percentage                   80.00%      
Trade Names No Longer Used                          
Goodwill [Line Items]                          
Impairment of intangible assets                   $ 8,000,000      
Discontinued Product Lines                          
Goodwill [Line Items]                          
Impairment of intangible assets                   $ 5,000,000 $ 14,000,000